American International Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-321
Closed -$34K 3189
2022
Q1
$34K Sell
321
-19
-6% -$3.63K ﹤0.01% 2951
2021
Q4
$87K Sell
340
-10
-3% -$3.04K ﹤0.01% 2777
2021
Q3
$124K Sell
350
-9
-3% -$3.54K ﹤0.01% 2696
2021
Q2
$179 Buy
359
+66
+23% +$32.2K ﹤0.01% 2574
2021
Q1
$139 Buy
293
+1
+0.3% +$1.94K ﹤0.01% 2551
2020
Q4
$515 Sell
292
-8
-3% -$10.6K ﹤0.01% 1728
2020
Q3
$289K Sell
300
-45
-13% -$48.3K ﹤0.01% 1910
2020
Q2
$401K Buy
345
+276
+400% +$249K ﹤0.01% 1712
2020
Q1
$61K Sell
69
-3
-4% -$3.24K ﹤0.01% 2584
2019
Q4
$63K Buy
+72
New +$56K ﹤0.01% 2821

Other funds holding KRRO

American International Group's KRRO Position: Q2 2022 in Review

American International Group sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 321 shares — an estimated $34K sold.

American International Group first reported a position in KRRO in Q4 2019 and held it in 10 quarters. The position peaked at $401K in Q2 2020. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

  • American International Group reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 321 Korro Bio shares in Q2 2022, an estimated $34K.
  • American International Group first reported a position in Korro Bio in Q4 2019 and held it in 10 quarters.
  • American International Group's Korro Bio position peaked at $401K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.